Phase II randomized trial on protracted 5-fluorouracil infusion plus oxaliplatin (FOX) versus capecitabine plus oxaliplatin (XELOX) as first-line treatment in advanced colorectal cancer (ACRC): Preliminary results of the Italian FOCA Study

A. Martoni; C. Pinto; F. Di Fabio; G. Lelli; A. L. Gentile; F. L. Rojas Llimpe; V. Mutri; P. L. Ballardini; S. Giaquinta; E. Piana

doi:10.1200/jco.2005.23.16_suppl.3617

Phase II randomized trial on protracted 5-fluorouracil infusion plus oxaliplatin (FOX) versus capecitabine plus oxaliplatin (XELOX) as first-line treatment in advanced colorectal cancer (ACRC): Preliminary results of the Italian FOCA Study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3617 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3617-3617 ◽

Cited By ~ 1

Author(s):

A. Martoni ◽

C. Pinto ◽

F. Di Fabio ◽

G. Lelli ◽

A. L. Gentile ◽

...

Keyword(s):

Colorectal Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Line Treatment ◽

First Line ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

TOMOX compared to FOLFOX4 as first-line treatment in patients (pts) with advanced colorectal cancer (ACRC): Preliminary results of a multicenter randomized phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3599 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3599-3599

Author(s):

C. Grávalos ◽

C. García-Girón ◽

A. I. León ◽

A. Salud ◽

B. Esteban ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Preliminary Results ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

TOMOX compared to FOLFOX4 as first-line treatment in patients (pts) with advanced colorectal cancer (ACRC): Preliminary results of a multicenter randomized phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3599 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3599-3599

Author(s):

C. Grávalos ◽

C. García-Girón ◽

A. I. León ◽

A. Salud ◽

B. Esteban ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Preliminary Results ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2014.12.020 ◽

2015 ◽

Vol 51 (4) ◽

pp. 473-481 ◽

Cited By ~ 10

Author(s):

Maria Di Bartolomeo ◽

Andrea Ciarlo ◽

Alessandro Bertolini ◽

Sandro Barni ◽

Claudio Verusio ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Medical Oncology ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Bevacizumab + folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (prot. GOIM 2601)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15048 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15048-15048

Author(s):

G. Colucci ◽

F. Giuliani ◽

V. Lorusso ◽

F. De Vita ◽

S. Cinieri ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Phase II trial alternating mFOLFOX 6 and FOLFIRI (FIREFOX) regimens in first-line treatment of advanced colorectal cancer in Japanese patients (KSCC 0701).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.3553 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 3553-3553

Author(s):

Y. Akagi ◽

S. Tokunaga ◽

Y. Emi ◽

Y. Kakeji ◽

T. Kusumoto ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

Japanese Patients ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC-03-2018)

BMC Cancer ◽

10.1186/s12885-020-07268-4 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Angela Damato ◽

Francesco Iachetta ◽

Lorenzo Antonuzzo ◽

Guglielmo Nasti ◽

Francesca Bergamo ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Phase II Study Alternating Mfolfox 6 and Folfiri (FIREFOX) Plus Bevacizumab (BEV) Regimen in First-Line Treatment of Advanced Colorectal Cancer in Japanese Patients (KSCC 0801)

Annals of Oncology ◽

10.1016/s0923-7534(20)32375-9 ◽

2012 ◽

Vol 23 ◽

pp. xi130

Author(s):

Y. Emi ◽

Y. Ogata ◽

Y. Akagi ◽

Y. Kakeji ◽

E. Oki ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Japanese Patients ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC) –A phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3712 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3712-3712 ◽

Cited By ~ 1

Author(s):

D. Tsavdaridis ◽

A. Athanasiadis ◽

N. Pissanidis ◽

M. Saleh ◽

A. Moshidis ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study

Oncology ◽

10.1159/000055350 ◽

2001 ◽

Vol 61 (1) ◽

pp. 36-41 ◽

Cited By ~ 9

Author(s):

Ch. Kouroussis ◽

J. Souglakos ◽

S. Kakolyris ◽

D. Mavroudis ◽

N. Malamos ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study

Annals of Oncology ◽

10.1093/annonc/mdi193 ◽

2005 ◽

Vol 16 (6) ◽

pp. 869-877 ◽

Cited By ~ 46

Author(s):

H.P. Kalofonos ◽

G. Aravantinos ◽

P. Kosmidis ◽

P. Papakostas ◽

T. Economopoulos ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text